Year: 2025
Type: article
Abstract: Targeted nanomedicine strategies offer improved selectivity, reduced toxicity, and personalized interventions in blood cancer treatment by integrating advanced carriers, ligand-based targeting, and AI-powered optimization.
Source: RSC Pharmaceutics
DOI: 10.1039/d5pm00090d
Institution: University of the Witwatersrand
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: diamond
Funder: National Research Foundation
Award: G4428704238
OpenAlex ID: W4411895145
